News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AHF: Gilead Sciences, Inc. (GILD)’s "Me Too" Quad AIDS Drug Offers Little Improvement, More Kidney Damage


7/6/2012 9:53:20 AM

LOS ANGELES--(BUSINESS WIRE)--Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.’s new four-drug HIV/AIDS pill, known as the “Quad,” renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.

Read at BioSpace.com

comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES